unilateral adrenal hyperplasia
Recently Published Documents


TOTAL DOCUMENTS

34
(FIVE YEARS 6)

H-INDEX

11
(FIVE YEARS 0)

Cureus ◽  
2021 ◽  
Author(s):  
Nagapratap Ganta ◽  
Suhrim Choe ◽  
Anish Kanukuntla ◽  
Priyaranjan Kata ◽  
Pramil Cheriyath

2021 ◽  
Vol 20 (2) ◽  
Author(s):  
Noor Ezmas Mahno ◽  
M. Rohaizak ◽  
AS. Nordashima ◽  
Y. Yazmin

A 73-year-old gentleman with a background history of long-standing hypertension and hyperlipidaemia presented with one-year history of persistent asymptomatic hypokalaemia associated with metabolic alkalosis. Within a few months, the hypertension worsened, needing increasing dose of anti-hypertensive agents. Biochemical test showed an elevated aldosterone-renin ratio but the computerized tomography (CT) scan of adrenal did not show any adrenal mass. Arterial stimulation venous sampling (ASVS) lateralized the lesion to the left side. A left retroperitoneal adrenalectomy was performed with immediate reversal of hypokalaemia and improvement of blood pressure control to only single anti-hypertensive agent.


Praxis medica ◽  
2021 ◽  
Vol 50 (1-2) ◽  
pp. 51-54
Author(s):  
Miloš Mijalković ◽  
Slavica Pajović ◽  
Aleksandar Jovanović ◽  
Maja Šipić

Introduction: Arterial hypertension is a major cardiovascular risk factor affecting about 10-40% of the adult population. Secondary endocrine hypertension most often results from excessive aldosterone secretion. Complications related to excessive aldosterone secretion include atrial fibrillation, myocardial infarction, myocardial fibrosis, left ventricular hypertrophy, stroke, and increased cardiovascular mortality. Case report: This report presents a hypotensive woman with hypertensive reactions, newly diagnosed unilateral hyperplasia of the left adrenal gland and secondary hyperaldosteronism. Due to good blood pressure and normalized electrolyte status as a result of antihypertensive drug therapy and absence of damage to target organs, surgical treatment of unilateral adrenal hyperplasia was postponed. Conclusion: In case of midlife and late-life hypertension, it is necessary to consider a cause in the patient's endocrine system. AUTHORS SUMMARY SRPSKI 2021; 50 (1,2) 51-54


2020 ◽  
Vol 360 (5) ◽  
pp. 607-609
Author(s):  
Kyriazoula Chatzianagnostou ◽  
Luca Morelli ◽  
Luca Pollina ◽  
Liborio Torregrossa ◽  
Alberto Clemente ◽  
...  

2019 ◽  
Vol 3 (Supplement_1) ◽  
Author(s):  
Marcela Rassi-Cruz ◽  
Leticia Vilela ◽  
Luiz Bortolotto ◽  
Luciano Drager ◽  
Maria Adelaide Pereira ◽  
...  

2014 ◽  
Author(s):  
Kamile Gul ◽  
Murat Sahin ◽  
Ayten Oguz ◽  
Fatih Yuzbasioglu ◽  
Hamide Sayar ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document